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We thank Drs Le-Xin Wang and Zeng-Shan Ma for their com-
ments on our publication.1 The authors state that pre- and postoper-
ative pulmonary arterial pressure and ventricular function are impor-
tant factors influencing long-term survival after corrective surgery.2,3
Therefore, they contend that without considering these factors in the
analyses of long-term survival after surgery, the sex differences we
reported require cautious interpretation.
We recognize that pulmonary arterial pressure and ventricular func-
tion are important factors influencing long-term outcome after sur-
gery.2,3 However, we did not have access to clinical information, and
therefore we could not include these factors in our analyses. Neverthe-
less, we question whether these factors might explain the worse
long-term survival of men after surgery in adulthood. To date, there is
little indication that pulmonary arterial hypertension or ventricular
dysfunction are more prevalent in men with congenital heart disease
than in women.4–6 Therefore, we do not expect that accounting for
pulmonary pressure and ventricular function would significantly influ-
ence our results regarding sex differences in long-term survival after
surgery. However, additional research on sex differences in adult
congenital heart disease is necessary to provide more answers.
Furthermore, our colleagues state that, in their experience, correc-
tive surgery in adults with congenital heart disease can be considered
curative in most cases, because in their center the vast majority enjoy
a good outcome with little or no need for reoperations.3 Although we
agree that for many patients corrective surgery might be considered
curative, our results show this is not necessarily true for all.
Furthermore, it is important to consider the follow-up period when
discussing the need for reoperations. It might be that the need for
reoperations can only be shown during a longer follow-up.
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